Fc receptors (FcR) are a group of cellular surface molecules that specifically recognize and bind homologous immunoglobulin via the Fc part and which mediate various biological functions. For each immunoglobulin heavy chain, there are corresponding FcR expressed on specific cells of all the major hematopoietic lineages. FcR for immunoglobulin G (IgG) form a heterogeneous group and link specific humoral and cellular immune responses and thus confer antigen specificity to phagocytic effector cells that lack receptors specific for antigen (51) . The functions triggered by FcR include phagocytosis, endocytosis, antibody-dependent cellular cytotoxicity, release of inflammatory mediators, and modulation of antigen presentation. Three types of murine and human FcR can be distinguished. All three receptors belong to the immunoglobulin supergene family, are associated with homo-and heterodimers, and also exist as soluble receptors (52) .
FcR are also expressed by some bacteria and have been typed according to their functional reactivities with different species and subclasses of IgG (6) . Remarkably, induction of FcR is also a property of certain coronaviruses (38) and of herpesviruses, including herpes simplex virus type 1 (HSV-1) and HSV-2 (1, 3, 54) , varicella-zoster virus (VZV) (37) , cytomegalovirus (CMV) (21, 27, 40, 55) , and Epstein-Barr virus (57) . Baucke and Spear (3) identified Fc-binding glycoprotein gE of HSV-1. In order to achieve full FcR activity, gE forms a complex with a second glycoprotein, gI (4, (23) (24) (25) . The FcR genes of the herpesviruses are not members of the immunoglobulin supergene family.
The biological role of FcR expressed by herpesviruses is unclear. The present concept, which is supported by in vitro data, is that the HSV-1 FcR is active in bipolar bridging of specific IgG (18) , which reduces the efficacy of virus neutralization (12) and antibody-dependent cellular cytotoxicity (15) . Induction of an FcR by a herpesvirus may also have adverse effects, since FcR induction by CMV has been reported to confer human immunodeficiency virus susceptibility to cells (34) .
We recently observed that in B-cell-deficient mice, the primary infection by murine CMV (MCMV) takes the same course in the presence and absence of antibody (26) . One explanation could be that functions specified by the virus, for instance, induction of FcR, could modulate the activity of antibodies. In order to test the potential immunological role of FcR, we therefore set out to identify genes coding for a potential FcR activity of MCMV. This should enable us to construct and test CMV mutants that harbor or lack this function. In this report, we describe the identification and genomic location of a gene coding for FcR, determined by a method involving injection of viral genomic DNA fragments and monitoring of the expression phenotype. The gene was sequenced and the protein was expressed by vaccinia virus.
MATERIALS AND METHODS
Cells, virus, and infection conditions. BALB.SV, a immortalized cell line of BALB/c murine embryonal fibroblasts (MEF) (11), was grown in Dulbecco's modified Eagle medium supplemented with 10% (vol/vol) fetal calf serum. MCMV (strain Smith, ATCC VR-194) was propagated on MEF as described previously (44) . The cells were infected by the technique of centrifugal enhancement of infectivity.
For selective expression of immediate-early proteins, the cells were infected in the presence of cycloheximide (50 Preparation of viral DNA. The MCMV DNA was prepared from the infected cells and purified by CsCl gradient centrifugation as described previously (16) .
Microinjection. 
'-3'), and the transcribed product was then subjected to PCR amplification with oligonucleotides RO (5'-AAGGATCCGTCGACATC-3') and B23-14.3-HindIII (5'-CCGAAGC1'CTCCATCTCGATCAACGG-3'). The primers contained the restriction sites, which allowed the cloning and sequencing of the amplified product.
Production of recombinant vaccinia viruses. Recombinant vaccinia virus expressing the complete MCMV FcR open reading frame (ORF) was generated as described previously (32) . Briefly, the 2,373-bp BamHI-BamHI fragment was cloned into the vaccinia virus expression vector p7.5K, which allows the expression of foreign proteins under the control of the 7.5-kDa early-late promoter. The virus recombinants were produced with the DNA of vaccinia virus strain Copenhagen. Recombinants expressing their respective MCMV FcR ORFs were selected by infecting HU TK-143 cells.
Nucleotide sequence accession number. The EMBL Data Library accession number for the nucleotide sequence reported in this article is X77798.
RESULTS
Identification of an MCMV early glycoprotein with IgG binding properties. A cytoplasmic FcR activity expressed following infection with human CMV has been reported by Furukawa et al. (21) . The expression of MCMV-induced immunoglobulin binding activity in the infected cells was tested accordingly. By indirect immunofluorescence, a strong cytoplasmic staining was observed with purified murine IgG but not with murine IgM, indicating that MCMV encodes a function similar to that encoded by human CMV ( To test whether the capacity to bind immunoglobulins is restricted to the Fc portion of the immunoglobulin molecule, Sepharose particles were coated with purified Fc fragments, purified F(ab)2 fragments, and complete IgG molecules. Affinity precipitation showed that gp86/88 is precipitated by IgG Fc fragments but not by IgG F(ab)2 fragments (Fig. 2c) Fig. 3 . Twentyfour hours after injection of complete undigested MCMV DNA (Fig. 3a) , a strong expression of FcR in the cytoplasm can be seen (Fig. 3e) (36) . Therefore, we assumed that the coinjection of the plasmid pIE111, containing the iel and the ie3 genes (36) , was necessary for the expression of the FcR gene in further experiments. This assumption was later proved to be correct (data not shown).
Several restriction enzymes were tested by monitoring cells by cytoplasmic staining after DNA injection. Whereas, for example, no positive signal resulted after cleavage of MCMV DNA with EcoRI, nearly 30 to 40% of injected cells were positive after digestion with ClaI. The ClaI digestion resulted in at least 29 MCMV DNA restriction fragments which were isolated and coinjected with the plasmid pIE111. Injection of isolated ClaI restriction fragments showed that the secondlargest (B) fragment of about 12 kbp must contain a gene which either encodes or induces the FcR protein (Fig. 3c) . This fragment was cloned into the pACYC177 vector, and subfragments of the cloned fragment were retested. Injection of various restriction subfragments led to the conclusion that the minimal fragment which still induced the expression of the FcR function is a 2.4-kbp fragment produced by digestion with BamHI and containing the expected EcoRI site (Fig. 3c) . This fragment was subcloned into the pEMBL18 vector for nucleotide sequencing (Fig. 3d ).
Nucleotide and amino acid sequences of the gene encoding FcR. The 2.4-kbp BamHI subfragment of the ClaI B fragment was sequenced with specific primers (Fig. 4) The amino acid sequence of the MCMV FcR was deduced from the nucleotide sequence of the fcrl ORF. The hydrophobic and hydrophilic domains of the protein were analyzed. A hydrophobic region at the N terminus represents a putative signal peptide sequence of 17 residues, according to the algorithms of von Heijne (53) . A second hydrophobic region of 18 amino acids probably representing the transmembrane region, which is followed by a 17-amino-acid cytoplasmic tail, was identified at the C terminus (positions 535 to 552). The putative transmembrane glycoprotein has 10 potential Nlinked glycosylation sites.
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At positions 68 to 71, the sequence contains the tripeptide Arg-Gly-Asp (RGD). This sequence represents a ligand recognition motif for several integrins (39, 56) . Proximal to the transmembrane region, a region rich in proline (P), glutamic acid (E), serine (S), and threonine (T), a PEST region (43, 45) , was identified (positions 458 to 490). This type of region is characteristic for eucaryotic proteins with intracellular halflives of less than 2 h (44, 46) .
Characteristics of thefcrl gene. To determine the expression kinetics of the fcrl mRNA, total cellular RNA was isolated at different times after infection and Northern (RNA) hybridization was performed. Hybridization with the 32P-labeled, single-strand-specific probes containing the fcrl ORF and generated by runoff synthesis (49) revealed the appearance of four transcripts that were 1.9, 3.3, 4.4, and 6.0 kb (Fig. 5) . All four transcripts originate from the same strand, since no hybridization was detected with a probe specific for the opposite strand (data not shown). On the basis of the size of fcrl mRNA, which can be predicted from the nucleotide sequence, and on the basis of the gene injection experiments, the 1.9-kb transcript must represent the mRNA for the fcrl gene.
Transcription was found to start as early as 2 h after infection and to continue throughout the MCMV replication cycle (Fig. 5a ). Maximal transcriptional activity was observed between 8 and 16 h p.i. The same filters were rehybridized with a probe specific for a cellular gene, the ,B-actin gene, to assess the amount of RNA loaded on the gel (Fig. Sb) .
The 5' end of the fcrl mRNA was determined by primer extension. A primer was hybridized 150 nt upstream of the putative start site. The resulting cDNA (Fig. 6a) is seen adjacent to the sequencing products with the same primer. The first nucleotide of the mRNA is the T at position 379, 31 nt downstream of the TATA box and 92 nt upstream of the ATG (Fig. 4) .
The 3' end of the fcrl transcript was determined by reverse VOL. 68, 1994   60  120  180  240   300  360  420   1  480  16  540   36  600  56  660  76  720  96  780  116  840  136  900  156  960  176  1020  196  1080  216  1140  236  1200  256  1260  276  1320  296  13 80  316  1440  336  1500  356  1560  376  1620  396  1680  416  1740  436  1800  456  1860  476  1920  496  1980  516  2040  536  2100  556  2160  2220 transcription of the mRNA and amplification of the cDNA (20) (Fig. 6b and c) . In brief, the primer (dT)17-R1-R0 was annealed to RNA and reverse transcription was performed. Amplification of the fcrl cDNA was achieved with fcrl-specific primer 5'-AGACAGACCATGCCATCG-3' and primer RO (Fig. 6b and c) . After sequencing of this amplified fragment, the 3' end of thefcrl mRNA could be located at position 2216, 18 nt downstream of the polyadenylation signal. This predicts a calculated size of 1,838 nt for the fcrl mRNA, which is in good agreement with the size of the mRNA identified by Northern hybridization.
Expression of the MCMV FcR by a recombinant vaccinia virus. A recombinant vaccinia virus expressing the MCMV FcR ORF was constructed in order to test whether the cloned gene indeed encodes a protein which binds the Fc fragment of IgG. The FcR gene product synthesized in vaccinia virus FcR-infected cells was characterized by immunoprecipitation of [35S]methionine-labeled proteins with purified IgG and with polyclonal anti-MCMV serum. Proteins with apparent molecular masses of 86 and 88 kDa were equally expressed in cells infected with the recombinant vaccinia virus. They were precipitated by both IgG and MCMV-specific antiserum (Fig. 7) . This result proved that the fcrl gene identified by microinjection is identical to the gene coding for the protein which is precipitated by IgG from MCMV-infected cell lysates.
Genomic localization of the fcrl gene. The fcrl gene was located by Southern analysis in the Hindlll J fragment of the MCMV genome (data not shown) between map units 0.838 and 0.846 (Fig. 8) . The gene is located upstream of the sggl gene (33) and a PL3 transcript (7) reported by Cardin et al.
Four transcripts of significantly different sizes were identified after hybridization with a gene-specific probe (Fig. 5) (21, 27) . At the cell surface, the reactivity is stronger with aggregated IgG than with monomeric IgG (19) . Generally, the level of surface FcR expression varies among herpesviruses, which led to controversial data with regard to surface expression of VZV FcR (for a review, see reference 30). The surface expression of human CMV FcR is thought to facilitate the entrance of viruses into CMV-infected cells (34) . We also observed that for MCMV-infected cells, the intracellular binding of monomeric IgG is much stronger and more consistent than the interaction at the cell membrane (data not shown). In the absence of a specific antiserum for the protein, the strong cytoplasmic expression of the Fc binding property was preferred for identifying the coding region in the genome.
Transcriptional is transcribed from the same strand in the same direction, and all four transcripts probably coterminate with the fcrl mRNA. This conclusion was based on the finding that after cDNA synthesis and PCR amplification, only a single fragment that defined the 3' end of the fcrl mRNA was obtained. Although this PCR method amplifies fragments in a certain size range, it is unlikely that a member of this mRNA family terminates further downstream, because another 1.3-kb early RNA has been mapped to the adjacent region (7). Multiple and longer transcripts from the same strand also occur in the regions of the gB and polymerase genes of MCMV and human CMV (17, 28, 31, 42, 47) as well as in the region encoding the gH of MCMV (41) .
The fcrl gene predicts an ORF with the potential to encode a protein of 569 amino acids. This protein is a type I glycoprotein with an N-terminal secretory signal sequence of 17 residues and a transmembranal region extending from positions 535 to 552 followed by a cytoplasmic tail of 17 amino acids. The size of an early glycoprotein which was detected in infected cells and which migrates at a relative mobility of 64 kDa after deglycosylation is also in good agreement with the predicted molecular mass of the fcrl gene product, and proof for identity was provided by vaccinia virus expression of fcrl. Because of the lack of a specific antibody, the characterization of the fcrl gene product has been limited to precipitation by IgG. Work to define the conditions of IgG binding by the fcrl product and its biochemical properties in more detail is in progress. Studies of the biochemical properties of human CMV proteins with Fc binding functions revealed four proteins of 38, 50, 65, and 130 kDa (5 (42) .
If the FcR of CMV is homologous with the receptor of alphaherpesviruses, which is a heterodimer composed of the glycoproteins gE and gI (25) , then the protein we describe is probably the homolog of gE. This conclusion is based on the facts that only the gE protein of HSV-1 has intrinsic Fc binding activity and that its interaction with gI endows gE with the ability to interact with both IgG monomers and aggregates. At 550 residues for HSV-1 gE and 623 for VZV gE, all three proteins fall into a similar size class. The two genes for HSV-1 and VZV gE have an identity of 19% and a similarity of 34%. A comparison of the amino acid sequence of HSV-1 gE with the sequence of fcrl reveals an identity of 14.3% and a similarity of 38.6%, and a comparison of the VZV gE sequence with the fcrl sequence reveals an identity and a similarity of 13.9 and 41.1%, respectively (data not shown). In addition, the N-terminal region of fcrl contains the RGD tripeptide cell adhesion motif shared by many cell adhesion molecules (13) and which is absent from the FcyR of HSV-1 and VZV. Finally, the sequence contains a PEST motif which is typical for proteins with a short half-life (43, 45) . The functional relevance of these sequence motifs and of the Fc binding property is unknown at present. At least three possibilities exist. The first is that the FcR indeed has a function that allows the virus to evade immune control, a function similar to the effect of the so-far-unknown early gene products affecting the export of peptide-loaded major histocompatibility complex class I molecules (9) . Second, the FcR property could be irrelevant for the in vivo function of the gene product and could perhaps indicate a propensity to interact with certain glycoproteins. The finding that the surface expression of the VZV FcR is rather weak and that in CMV the protein is mainly in the cytoplasm and is associated with the tegument of the virion may indicate such a possibility. The third possibility is that the protein has more than one function. Recent 
